Europe risks losing biosolutions leadership to China without faster regulations
Summary
Europe is at risk of losing its position as a global leader in biosolutions to China due to sluggish regulation and approval processes. Criticism has mounted against the European Union's lengthy procedures, which stand in stark contrast to the faster regulatory environments found elsewhere. Meanwhile, China is actively enhancing its research, manufacturing, and intellectual property initiatives in biosolutions, strengthening its competitiveness against established leaders in the field.
Analysis
Europe: Europe, encompassing the European Union and its regulatory framework, holds a competitive edge in biosolutions through advanced research in enzymes, microorganisms, and related technologies. The region is actively addressing industrial competitiveness challenges as China accelerates in the sector. In this news, European policymakers are urged by industry leaders to reform approval processes to retain leadership. Novonesis: Novonesis A/S is a Danish biotechnology company and the world's largest producer of industrial enzymes, delivering biosolutions across industries including food, agriculture, and energy. Its President and CEO Ester Baiget recently emphasized the company's global operations and innovation focus at events in Europe. The firm is central to the news as its CEO publicly addressed regulatory risks affecting Europe's position versus China. Regulation: European Union processes for approving biosolutions face criticism for delays that contrast with faster regulatory environments elsewhere. Competition: China is expanding research, manufacturing, and intellectual property efforts in biosolutions, positioning it to challenge established leaders.
Categories
tech
Related sources
- https://www.global-agriculture.com/biologicals/rovensa-next-to-distribute-novonesis-biosolutions-for-plant-health-in-the-united-states/
- https://ecfr.eu/publication/the-future-is-fermented-how-europe-can-succeed-in-the-next-industrial-race/
- https://www.politico.eu/research-and-analysis/biotechnology-at-scale-europes-next-competitiveness-test-report/
- https://www.business-standard.com/industry/news/novonesis-plans-6-660-cr-investment-in-maharashtra-biosolutions-facility-126090201277_1.html
- https://www.fas.usda.gov/data/gain/2026/06/european-union-european-parliament-passes-landmark-new-genomic-techniques-regulation
- https://www.ad-hoc-news.de/boerse/news/corporate-news/novonesis-stock-gains-support-from-a-eur-75-million-buyback/70106477
- https://www.bastillepost.com/global/article/5963988-chinas-green-policy-stability-boosts-long-term-foreign-investment-novonesis-ceo
- https://www.bloomberg.com/news/articles/2026-09-15/novonesis-ceo-says-eu-red-tape-risks-biosolutions-lead-to-china
- https://www.globenewswire.com/news-release/2026/09/02/3354859/0/en/novonesis-to-build-next-generation-enzyme-production-facility-in-india.html
- https://www.novonesis.com/en/investors/annual-report/message
- https://www.securities.io/novonesis-approves-e1-billion-inaugural-buyback-as-8-h1-organic-growth-lifts-2026-outlook/
- https://www.pharmexec.com/view/addressing-china-rise-biotech-removing-barriers-john-stanford